BIOCRYST PHARMACEUTICALS, INC. Share Price
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Share Price of $10.00 per share as of 2014-06-30, per its 10-Q filed 2014-11-07.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2016-02-26
- 2014-06-30: Share Price $10.00.
- 2013-12-31: Share Price $1.85.
- 2013-08-31: Share Price $4.40.
- 2013-08-06: Share Price $4.40.
| Period end | Share Price |
|---|---|
| 2014-06-30 | $10.00 10-Q · filed 2014-11-07 |
| 2013-12-31 | $1.85 10-K · filed 2016-02-26 |
| 2013-08-31 | $4.40 10-K · filed 2016-02-26 |
| 2013-08-06 | $4.40 10-Q · filed 2013-11-08 |
| 2012-12-31 | $4.08 10-K · filed 2016-02-26 |
| 2012-03-15 | $5.23 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |